(S)-N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-hydroxypentyl)-1H-indole-2-carboxamide

ID: ALA4514713

PubChem CID: 155539564

Max Phase: Preclinical

Molecular Formula: C20H29N3O3

Molecular Weight: 359.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(C)[C@H](NC(=O)c1cc2ccccc2n1CCCCCO)C(N)=O

Standard InChI:  InChI=1S/C20H29N3O3/c1-20(2,3)17(18(21)25)22-19(26)16-13-14-9-5-6-10-15(14)23(16)11-7-4-8-12-24/h5-6,9-10,13,17,24H,4,7-8,11-12H2,1-3H3,(H2,21,25)(H,22,26)/t17-/m1/s1

Standard InChI Key:  IEZMJVDWIFQOBY-QGZVFWFLSA-N

Molfile:  

 
     RDKit          2D

 26 27  0  0  0  0  0  0  0  0999 V2000
   29.4561  -21.8221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9766  -21.1641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9852  -22.4903    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2022  -22.2430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1983  -21.4194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4837  -21.0107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7724  -21.4286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7803  -22.2553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4955  -22.6562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2448  -23.2693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6994  -23.8857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9631  -24.6647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4177  -25.2811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2774  -21.8168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6947  -22.5259    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.6855  -21.1064    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.5160  -22.5206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6773  -26.0600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9292  -23.2298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9200  -21.8061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7413  -21.8008    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.5068  -21.1011    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.5252  -23.9442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7505  -23.2245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1361  -26.6723    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.3368  -23.9379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  5  1  0
  4  3  1  0
  3  1  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  3 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
  1 14  1  0
 14 15  1  0
 14 16  2  0
 15 17  1  0
 13 18  1  0
 17 19  1  6
 17 20  1  0
 20 21  1  0
 20 22  2  0
 19 23  1  0
 19 24  1  0
 18 25  1  0
 19 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4514713

    ---

Associated Targets(Human)

CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 359.47Molecular Weight (Monoisotopic): 359.2209AlogP: 2.43#Rotatable Bonds: 8
Polar Surface Area: 97.35Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.13CX LogD: 2.13
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.63Np Likeness Score: -0.50

References

1. Moir M, Lane S, Lai F, Connor M, Hibbs DE, Kassiou M..  (2019)  Strategies to develop selective CB2 receptor agonists from indole carboxamide synthetic cannabinoids.,  180  [PMID:31319265] [10.1016/j.ejmech.2019.07.036]

Source